TY - JOUR
T1 - New frontiers in the treatment and prevention of migraine
T2 - A closer look at the role of emerging GCRP targeted therapies
AU - Friedman, Deborah I.
N1 - Publisher Copyright:
© 2019 National Association of Managed Care Physicians, Inc.. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Migraine is a common neurologic disorder that significantly impacts a patient’s quality of life and ability to work and is costly to treat. Although numerous agents have been available for preventing migraine, none was specifically designed to target the underlying pathologic process. The new class of agents is targeting one of these underlying pathologic processes.
AB - Migraine is a common neurologic disorder that significantly impacts a patient’s quality of life and ability to work and is costly to treat. Although numerous agents have been available for preventing migraine, none was specifically designed to target the underlying pathologic process. The new class of agents is targeting one of these underlying pathologic processes.
UR - http://www.scopus.com/inward/record.url?scp=85118994008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118994008&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85118994008
SN - 1094-1525
VL - 22
SP - 13
EP - 19
JO - Journal of Managed Care Medicine
JF - Journal of Managed Care Medicine
IS - 2
ER -